Scientists at Public Health England say the first real-world data shows the Pfizer-BioNTech and AstraZeneca-Oxford are nearly as effective against the emerging Indian strain of COVID-19 as they were against the so-called UK 'Kent' variant. Germany says it will donate 100 million euros ($121.83 million) to COVAX along with 30 million surplus doses with J&J also committing 200 million doses to the global facility.
Latest Video
New Stories
-
Patients and clinicians defend MS treatment choice during review stakeholder meeting
November 5, 2026 - - Latest News -
Vaccines dominate public health spending but prevention investment slips
November 5, 2026 - - Latest News -
Increased accountability can be the only response to expanding authority
November 5, 2026 - - Latest News -
Sydney summit program focused on the reshaping power of AI
November 4, 2026 - - Latest News -
Is the reluctance to revisit term limits because they are such an obvious change?
November 4, 2026 - - Latest News -
Does new report suggest that patient voice reforms are stalling?
November 4, 2026 - - Latest News -
Medicines industry faces tough PBS talks, but will it be the most challenging ever?
November 3, 2026 - - Latest News
